We found LILRB1 expression generally lower than CD33 across subtypes, with the highest expression observed in monocytic/monoblastic/myelomonocytic AML and AML with chromosome 6 abnormalities (Fig. 8A, Supplementary Fig. 8A). This evidence concerns the gene CD33 and acute myeloid leukemia.